Cerebral Microembolism in Cardiology (ZEMEK)
Cerebral Microembolism in Interventional Cardiology Procedures
Sponsor: Insel Gruppe AG, University Hospital Bern
Listed as NCT03802760, this observational or N/A phase trial focuses on Cerebral Embolism and remains completed. Sponsored by Insel Gruppe AG, University Hospital Bern, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jul 2023 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2022 — Dec 2022 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Oct 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Dec 2020 [monthly]
Recruiting
-
Feb 2019 — Sep 2019 [monthly]
Recruiting
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Insel Gruppe AG, University Hospital Bern
For direct contact, visit the study record on ClinicalTrials.gov .